The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A*02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition.
 
Vanessa Tubb
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Jennifer Ma
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics; Fate Therapeutics; Halozyme; Kite, a Gilead company; Neogene Therapeutics; Teva; Urogen pharma
 
Karen Buchner
Employment - Neogene Therapeutics
 
Sander Eshuis
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Michelle Mojadidi
Employment - Instil Bio; Neogene Therapeutics
Stock and Other Ownership Interests - Instil Bio; Neogene Therapeutics
 
Xiangjun Kong
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Paula Kroon
Employment - Neogene Therapeutics a member of the AstraZeneca Group
Stock and Other Ownership Interests - Neogene Therapeutics a member of the AstraZeneca Group
Patents, Royalties, Other Intellectual Property - Neogene Therapeutics
 
Aastha Sareen
Employment - Neogene Therapeutics
 
Rojina Duwal
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Laura Bies
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Julia Walker
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Robbert Spaapen
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Bas Stringer
No Relationships to Disclose
 
Oscar Krijgsman
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Helicia Paz-Chang
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
Travel, Accommodations, Expenses - Neogene Therapeutics
 
Yoonjung Shin
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
Patents, Royalties, Other Intellectual Property - Patent WO2022046760A3: T cells with improved functionality
 
Thomas Kuilman
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - AstraZeneca; Neogene Therapeutics
 
Jeroen van Heijst
Employment - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
 
Gavin Bendle
Employment - Neogene Therapeutics
Leadership - Neogene Therapeutics
Stock and Other Ownership Interests - Neogene Therapeutics
Patents, Royalties, Other Intellectual Property - Neogene Therapeutics
 
Arianne Perez
Employment - Neogene Therapeutics
Leadership - Neogene Therapeutics
Stock and Other Ownership Interests - Allogene Therapeutics; Cellectis; Century Therapeutics; Kite, a Gilead company; Neogene Therapeutics
Patents, Royalties, Other Intellectual Property - Patents resulting from work at Kite Pharma and Kite, a Gilead company
Travel, Accommodations, Expenses - Neogene Therapeutics